Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Management
Filter     Order     Display # 
Date Item Title
26 Jul 2008 Andreas Fibig named new Chairman of the Board of Management of Bayer Schering Pharma
26 Jun 2008 Further steps in generation change at Boehringer Ingelheim
05 Feb 2008 Acorda Therapeutics Announces Acquisition of Aminopyridine and Pre-Clinical Assets from Neurorecovery, Inc.
18 Dec 2007 Sidney Taurel to Retire as Lilly CEO; John Lechleiter Named as Successor
09 Oct 2007 GlaxoSmithKline appoints Andrew Witty CEO designate
02 Oct 2007 Jurgen Schwiezer named new CEO Division Roche Diagnostics
12 Sep 2007 Evotec Sells its Chemical Development Business to Aptuit for GBP 31.5m (approx. EUR 46.4m; US$ 63.9m) in Cash
23 Aug 2007 Pfizer names Frank A. D'Amelio Chief Financial Officer
20 Aug 2007 PDL BioPharma announces internal CEO investigation found no credible evidence of improper personal conduct or breach of fiduciary duty
10 Aug 2007 ImClone Systems Appoints John H. Johnson Chief Executive Officer
01 Aug 2007 FDA Advisory Panel votes 22 to 1 for Avandia(R) to remain available to patients in the US
 
<< Start < Prev 1 Next > End >>
Results 1 - 11 of 11

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Toll-Like Receptor (TLR) Agonists & Antagonists

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics